Trospium Chloride Tablet, Film Coated
Product Images NDC 0904-7619

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Trospium Chloride (NDC 0904-7619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 2 (Figure 2)

A line graph comparing the mean change (± SE) over 1, 4, and 12 weeks of treatment between placebo and Trospium Chloride groups. The graph shows greater change for Trospium Chloride compared to placebo, with p-values indicating statistical significance at weeks 4 and 12.*

FDA Label Image

Figure 3 (Figure 3)

A line graph comparing mean (± SE) change over time between placebo and Trospium Chloride 20 mg tablets. The X-axis shows time points at days 1, 4, and 12. Two data series are displayed: placebo with open circles and Trospium Chloride with filled circles, showing decreased values over time. P-values are noted at each time point, indicating statistical comparison between groups.*

FDA Label Image

Figure 4 (Figure 4)

A line graph illustrating the mean (± SE) change over treatment weeks 1, 4, and 12 for two groups: placebo (N=325) and Trospium Chloride (N=323). The Trospium Chloride group shows a greater decrease in mean change over time compared to placebo, with statistically significant p-values (0.004, <0.001) noted at different time points.*

FDA Label Image

Figure 5 (Figure 5)

A line graph comparing the mean (± SE) change over 12 weeks of treatment between Trospium Chloride and placebo groups. The x-axis represents weeks of treatment (1, 4, 12), and the y-axis shows mean change values. Trospium Chloride shows a greater mean change reduction than placebo, with significance at each time point (p<0.001). The graph includes sample sizes for placebo (N=325) and Trospium Chloride (N=323).*

FDA Label Image

Graph (Graph)

A line graph showing the mean plasma concentration (ng/mL) over time (hours post-dose) for a single 20 mg oral dose of Trospium Chloride tablets in healthy volunteers. The graph includes error bars representing standard deviation, illustrating the concentration peak around 2-4 hours post-dose, followed by a gradual decline up to 48 hours.*

FDA Label Image

Label 500 Count (Label 500 Count)

Label for Trospium Chloride 20 mg film-coated tablets by Major Pharmaceuticals. The package contains 500 tablets prescribed by a pharmacist. The label includes storage instructions to keep at 20 to 25°C and information about the drug being USP standard. It displays the NDC 0904-7619-40 and a barcode, with no varnish indicated for the label surface.*

FDA Label Image

Label 60 Count (Label 60 Count)

Label for Trospium Chloride 20 mg film-coated oral tablets by Major Pharmaceuticals. The label shows the product name, strength, dosage form, and quantity of 60 tablets. It includes a barcode, NDC 0904-7619-52, storage instructions, and dispensing directions. The label highlights 'Rx Only' and advises pharmacists to provide the Patient Information Leaflet separately.*

FDA Label Image

Structure-description (Structure Description)

Chemical structure of Trospium Chloride showing the tropane ring with a positively charged nitrogen, an ester linkage, two attached phenyl rings, a hydroxyl group, and a chloride ion (Cl-). This structure represents the active ingredient Trospium Chloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.